Gaithersburg, MD, United States of America

Qun Du

USPTO Granted Patents = 9 (Patent Applications = 11)

CIPO Patents = 1 (Patent Applications = 9)

EPO Patents = 2 (Patent Applications = 10)

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 24(Granted Patents)

Company Filing History:

Boston Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2017-2024

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12065496 - Antibody molecules and conjugates (2024-08-20),

2. 11578119 - Antibodies directed againstleukotoxins (2023-02-14),

3. 11529415 - Antibodies specific for IL-21 and uses thereof (2022-12-20),

4. 11168133 - Combinations of anti-antibodies (2021-11-09),

5. 11059884 - Antibodies directed againstleukotoxins (2021-07-13),

6. 10588969 - Antibodies specific for IL-21 and uses thereof (2020-03-17),

7. 10150815 - Method of treating cancer with humanized anti-OX40 antibodies (2018-12-11),

8. 10022443 - Antibodies specific for IL-21 and uses thereof (2018-07-17),

9. 9738723 - Humanized anti-OX40 antibodies and uses thereof (2017-08-22),

Title: The Innovative Contributions of Qun Du

Introduction

Qun Du is a prominent inventor based in Gaithersburg, MD (US), known for his significant contributions to the field of biotechnology. With a total of 9 patents to his name, Du has made remarkable advancements in the development of antibody molecules and their applications in cancer treatment and infection prevention.

Latest Patents

Among his latest patents, Du has developed antibody molecules that specifically bind to the epidermal growth factor receptor (EGFR) and/or c-Met. These antibody molecules and their conjugates are particularly valuable in the treatment of cancer. Additionally, he has worked on leukotoxin-binding antibodies and antigen-binding fragments, which can be utilized to detect leukotoxin and aid in methods of treating and preventing infections.

Career Highlights

Throughout his career, Qun Du has been associated with notable companies such as MedImmune Limited and Boston Pharmaceuticals, Inc. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Du has collaborated with several professionals, including Melissa Marie Damschroder and Christine Tkaczyk, who have played a role in his innovative projects.

Conclusion

Qun Du's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to impact cancer treatment and infection prevention, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.